UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Holdings in National Research Co. (NASDAQ:NRC)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of National Research Co. (NASDAQ:NRCFree Report) by 3.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 38,565 shares of the company’s stock after buying an additional 1,148 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in National Research were worth $680,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of NRC. SG Americas Securities LLC boosted its position in shares of National Research by 35.0% during the fourth quarter. SG Americas Securities LLC now owns 7,298 shares of the company’s stock worth $129,000 after buying an additional 1,893 shares during the period. Principal Financial Group Inc. boosted its position in shares of National Research by 10.7% during the fourth quarter. Principal Financial Group Inc. now owns 12,018 shares of the company’s stock worth $212,000 after buying an additional 1,161 shares during the period. Bank of New York Mellon Corp boosted its position in shares of National Research by 88.5% during the fourth quarter. Bank of New York Mellon Corp now owns 217,212 shares of the company’s stock worth $3,832,000 after buying an additional 101,957 shares during the period. Proficio Capital Partners LLC purchased a new position in shares of National Research during the fourth quarter worth $283,000. Finally, Norden Group LLC purchased a new position in National Research in the fourth quarter valued at $182,000. 47.26% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at National Research

In other National Research news, major shareholder Patrick E. Beans purchased 2,500 shares of the business’s stock in a transaction on Monday, May 12th. The shares were bought at an average cost of $13.59 per share, for a total transaction of $33,975.00. Following the completion of the purchase, the insider now directly owns 35,003 shares in the company, valued at approximately $475,690.77. This represents a 7.69% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 8.10% of the stock is currently owned by company insiders.

National Research Trading Down 0.9%

NASDAQ:NRC opened at $16.07 on Thursday. The firm has a market cap of $366.15 million, a PE ratio of 15.30 and a beta of 0.38. The stock has a fifty day moving average price of $12.75 and a 200 day moving average price of $15.30. National Research Co. has a 12-month low of $9.76 and a 12-month high of $27.07. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 1.30.

National Research (NASDAQ:NRCGet Free Report) last released its earnings results on Monday, April 28th. The company reported $0.25 earnings per share (EPS) for the quarter. The firm had revenue of $33.55 million during the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%.

National Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Friday, June 27th. This represents a $0.48 dividend on an annualized basis and a yield of 2.99%. National Research’s dividend payout ratio (DPR) is presently 46.60%.

National Research Company Profile

(Free Report)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

Recommended Stories

Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Co. (NASDAQ:NRCFree Report).

Institutional Ownership by Quarter for National Research (NASDAQ:NRC)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.